Ranolazin:  mechanism of antianginal effects

Özdemir, Murat

Journal Metrics

Impact Factor (2024): 0.9
CiteScore (2023): 1.3
Source Normalized Impact
per Paper:
0.315
SCImago Journal Rank: 0.250

52/8Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

Ranolazin: mechanism of antianginal effects [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2016; 44(3): 8-12 | DOI: 10.5543/tkda.2016.72626

Ranolazin: mechanism of antianginal effects

Murat Özdemir
Gazi Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara

Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a “metabolic modulator”, ranolazine is now considered to be a “late sodium current blocker”. This review tries to summarize the mechanism of antianginal effects of ranolazine.

Corresponding Author: Murat Özdemir, Türkiye
Manuscript Language: Turkish

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar